Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit

Brianne Rogers, Allison Olmsted, Millie Mo

Open source

DOI
10.18553/jmcp.2026.32.11.1386
Published
2026-11
Container
Journal of Managed Care & Specialty Pharmacy
Publisher
Academy of Managed Care Pharmacy
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18553/jmcp.2026.32.11.1386,
  title = {Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit},
  author = {Brianne Rogers and Allison Olmsted and Millie Mo},
  year = {2026},
  journal = {Journal of Managed Care \& Specialty Pharmacy},
  doi = {10.18553/jmcp.2026.32.11.1386},
  url = {https://doi.org/10.18553/jmcp.2026.32.11.1386}
}

RIS

TY  - JOUR
TI  - Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit
AU  - Brianne Rogers
AU  - Allison Olmsted
AU  - Millie Mo
PY  - 2026
JO  - Journal of Managed Care & Specialty Pharmacy
DO  - 10.18553/jmcp.2026.32.11.1386
UR  - https://doi.org/10.18553/jmcp.2026.32.11.1386
ER  - 

APA

Rogers, B., Olmsted, A., & Mo, M. (2026). Total cost of care for long-acting injectable antipsychotics for schizophrenia: Pharmacy vs medical benefit. Journal of Managed Care & Specialty Pharmacy. https://doi.org/10.18553/jmcp.2026.32.11.1386

Source records